Posted by Mary Wimberley on 2010-12-15

Samford University pharmacy professor Kim Benner, Pharm.D., BCPS, FASHP, was recently chosen to serve as a pediatric therapeutics evaluator for a National Institutes of Health initiative.

Dr. Benner is among 22 experts from around the country who were selected to serve as evaluators for the 2010-11 Best Pharmaceuticals for Children Act (BPCA) Priority List of Needs in Pediatric Therapeutics.  The program is a component of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

The panel’s task was to evaluate and prioritize applications for NIH funding. The process, which involved assessing some 67 nominations on the basis of evidence, impact and population, was completed in November.

Benner was nominated for the panel by the American Society of Health-System Pharmacists, which she serves as chair of its Council on Therapeutics. 

She is a professor of pharmacy practice at Samford’s McWhorter School of Pharmacy and pediatric clinical pharmacy specialist at Children’s Health System in Birmingham.

Samford is a leading Christian university offering undergraduate programs grounded in the liberal arts with an array of nationally recognized graduate and professional schools. Founded in 1841, Samford is the 87th-oldest institution of higher learning in the United States. The Wall Street Journal ranks Samford 1st nationally for student engagement and U.S. News & World Report ranks Samford 66th in the nation for best undergraduate teaching and 104th nationally for best value. Samford enrolls 5,683 students from 47 states and 19 countries in its 10 academic schools: arts, arts and sciences, business, divinity, education, health professions, law, nursing, pharmacy and public health. Samford fields 17 athletic teams that compete in the tradition-rich Southern Conference, and ranks 6th nationally for its Graduation Success Rate among all NCAA Division I schools.